Skip to content

Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration

Feasibility and Acceptability Study of a Non Weight-bearing Physical Activity Program for People With Diabetic Foot Ulceration (DB ACTIV)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06092827
Acronym
DB-ACTIV
Enrollment
12
Registered
2023-10-23
Start date
2023-12-01
Completion date
2026-07-16
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary, Diabetic Foot, Physical Inactivity

Brief summary

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.

Detailed description

Objectives: 1. Evaluate the acceptability of a non-weight bearing physical activity (PA) program; 2. Assess the feasibility of the PA program and the data collection procedure; 3. Evaluate the feasibility of a submaximal exercise test for cardiorespiratory capacity; and 4. Verify the sensitivity of dependent variables to respond to a physical activity program (e.g., cardiorespiratory capacity, cardiovascular and metabolic risk factors, quality of life, PA level). Type of study: Feasibility and acceptability study with a pre-post evaluative design. Intervention: Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week. Subjects: * 10-12 persons with an active diabetic foot ulcer * 2-3 kinesiologists Data collection: * Sociodemographic and health questionnaire (age, sex, gender, marital status, education level, employment status, average annual family income, medical and health history, pharmacological and non-pharmacological treatments); * Feasibility assessment: PA (physical activity) logbook including 1) the number of supervised and unsupervised sessions completed, 2) the duration of each session, 3) participation rate (number of patients recruited/number of eligible patients), 4) attrition rate (number of participants who completed the follow-ups/number of participants recruited), and 5) perceived facilitators and barriers; * Acceptability assessment: 1) Treatment Acceptability and Preference (TAP) Questionnaire, seven to nine additional questions to assess the use of provided material resources and required safety checks (capillary blood glucose and wound inspection) and collection of participants' feedback, and 2) Client Satisfaction Questionnaire (CSQ-8); * Assessment of the sensitivity of dependent variables to respond to the PA program\*: 1) estimation of VO2max by a submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), 2) average daily step count over seven days at the waist and in the offloading boot at times 0, 4, 8, and 12 weeks, 3) Global Physical Activity Questionnaire (GPAQ), 3) clinical examination (height, weight, body mass index, waist circumference, body fat percentage, blood pressure, resting heart rate, characteristics of the DFU and classification (SINBAD), 4) paraclinical examinations (venous blood glucose, glycated hemoglobin, lipid profile), 5) neuropathic pain questionnaire (DN4), 6) Epworth sleepiness scale, quality of life questionnaire (EQ-5D-5L), 7) questionnaire on motivation to practice PA. * Health and safety parameter measurements: electrocardiogram, oxygen saturation, estimated glomerular filtration rate, urine albumin/creatinine ratio, complete blood count. * Data collection at 24 and 36 weeks is also planned for participants who agree to be contacted after completing the 12-week PA program.

Interventions

BEHAVIORALNon weight-bearing physical activity program

12-week duration, 2 supervised trainings/week, 1 unsupervised home-based training/week Aerobic, resistance and flexibility exercises

Sponsors

Université du Québec à Trois-Rivières
Lead SponsorOTHER
Fondation Santé Trois-Rivières
CollaboratorUNKNOWN
Centre intégré universitaire de santé et services sociaux Mauricie et Centre-du-Québec (CIUSSS MCQ)
CollaboratorUNKNOWN
Université de Montréal
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Feasibility and acceptability study

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

For individuals with a diabetic foot ulcer: Inclusion: * Male or female * Aged over 18 up to 75 years * Willing to engage in PA (physical activity) * Committed to following wound care recommendations to the best of their ability for the duration of the study * Understand and read French. Exclusion: * Uncontrolled DFU infection * Use of a non-removable offloading modality (total contact cast) * Uncontrolled hyperglycemia (HbA1c ≥ 10.0% or fasting blood glucose ≥ 16.0 mmol/L for ≥ 2 consecutive days) confirmed by blood sample results during the initial assessment or access to recent blood test results (within the last 3 months) or the log of home capillary blood glucose readings * Participation in sports or regular intense physical activities (≥ 2 times per week) * The following pre-existing heart problems: a cardiovascular event (myocardial infarction, heart surgery, etc.) in the last 3 months, unstable cardiovascular disease (uncontrolled hypertension, i.e., ≥ 160/90 mmHg, uncompensated heart failure, etc.), chest pain and exertional dyspnea and/or uninvestigated intermittent claudication * Recent neurovascular problem (stroke, transient ischemic attack, etc.) in the last 3 months * Health problem that the research team considers a contraindication to participating in the study * Diabetes complication making moderate-intensity PA unsafe, such as untreated proliferative diabetic retinopathy or a sensitivity disorder to hypoglycemia, critical ischemia of one or both lower limbs. For kinesiologists: Inclusion: * Have completed a bachelor's degree in kinesiology * Understand, read, and speak French. Exclusion: None

Design outcomes

Primary

MeasureTime frameDescription
Acceptability of physical activity interventionAt time 12 weeksTreatment Acceptability and Preference (TAP) Questionnaire, minimum score 0/maximum score 16 with higher score meaning a greater acceptability
Satisfaction towards physical activity interventionAt time 12 weeksClient Satisfaction Questionnaire (CSQ-8), minimum score 8/maximum score 32 with higher score meaning a higher satisfaction
Feasibility of physical activity interventionAt time 12 weeksPhysical activity logbook, number of sessions completed with higher number meaning a greater feasibility

Secondary

MeasureTime frameDescription
Lipid profile (total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, non-HDL cholesterol)At times 0 and 12 weeksVenipuncture, g/L
Neuropathic pain (if present)At times 0 and 12 weeksNeuropathic pain (DN4) Questionnaire, 10 yes/no questions, higher number of yes indicates more severe neuropathic pain
Estimated VO2maxAt times 0 and 12 weekssubmaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), mL/kg/min
Average daily step count over seven daysAt times 0, 4, 8, and 12 weeksAt the waist and in the offloading boot using a FitBit Zip, number of steps
Physical activity levelAt times 0 and 12 weeksGlobal Physical Activity Questionnaire (GPAQ), no minimum/maximum, details number of minutes/number of days per week of physical activity according to type of activity (work, leisures, commute, sedentary time)
HeightAt time 0Standing with rigid measuring rod, cm
WeightAt times 0 and 12 weeksStanding on beam balance scale, kg
Waist circumferenceAt times 0 and 12 weeksWith flexible measuring tape above ombilic, cm
Body fat percentageAt times 0 and 12 weeksWith bio-impedance balance, %
Arterial blood pressureAt times 0 and 12 weeksWith automatic blood pressure monitor, mm Hg
Resting heart rateAt times 0 and 12 weeksWith automatic blood pressure monitor, bpm
Wound measurements (width, length, depth)At times 0, 4, 8 and 12 weeksWith flexible ruler
Classification of the ulcerAt times 0, 4, 8 and 12 weeksUsing SINBAD system, 6 categories graded 0 or 1 for a minimum of 0 and maximum of 6, with higher score meaning a more complicated ulcer
Non fasting venous blood glucoseAt times 0 and 12 weeksWith venipuncture, mmol/L
Sleep apnea symptomsAt times 0 and 12 weeksEpworth sleepiness scale, minimum score of 0/maximum score of 24, higher score makes sleep apnea more likely
Glycated hemoglobinAt times 0 and 12 weeksWith venipuncture, %
Reported quality of lifeAt times 0 and 12 weeksQuality of life questionnaire (EQ-5D-5L), minimum score of 5/maximum of 25 + 10cm visual analog scale, higher score represents a lower quality of life + 10cm being the best health condition possible
Questionnaire on motivation to practice physical activityAt times 0 and 12 weeksWith the Behavioural Regulation in Exercise revised Questionnaire (BREQ-2), 5 motivation categories graded from 0 to 4, Intrinsic (4 questions), Identified (3 questions), Introjected (3 questions), External (4 questions) and Amotivation (4 questions), with lower scores meaning lesser motivation for each category

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORMagali Brousseau-Foley, MD

Université du Québec à Trois-Rivières

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026